Dublin, Dec. 08, 2025 (GLOBE NEWSWIRE) -- The "Companion Animal Pharmaceuticals Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. The Companion Animal ...
(MENAFN- GlobeNewsWire - Nasdaq) Key opportunities in the companion animal pharmaceuticals market include developing advanced biologics and targeted therapies driven by increased pet ownership and ...
NDT Pharmaceuticals, Inc.’s (OTC: NDTP) wholly-owned subsidiary Good Salt Life, Inc., a pioneer in innovative surface ...
Exploring With Josh on MSN
What happened to Shigeta Animal Pharmaceuticals?
Shigeta Animal Pharmaceuticals, established in 1984 in Toyama Prefecture, was notable for developing the first canine/feline ...
Animal rights groups celebrate, but the Trump administration is light on specifics about phasing out federally funded medical ...
A rare moment of bipartisan progress has emerged with the Senate’s unanimous passage of the FDA Modernization Act 3.0, ...
Exploring clinical development plan options including a controlled human infection model (CHIM) and a Phase 2/3 adaptive ...
The healthcare industry has never been a great source of dividends -- that alone makes these companies exceptional.
Overcoming acquired treatment resistance is one of the major challenges in the fight against cancer. While combination ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback